BRANFORD, Conn., Feb. 28, 2008 (PRIME NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM), a medical device company focused on innovative, non-invasive monitoring that is vital to patient care, today announced receipt of FDA 510(k) clearance for expanded indications for use of its FORE-SIGHT(r) Cerebral Oximeter Infant Sensor to include the neonatal patient population above 2500g weight.
